Skye retains CMAX Clinical Research for Phase I glaucoma treatment trial
Skye Bioscience has retained CMAX clinical Research for Phase I trial of its SBI-100 OE being developed for potential treatment of glaucoma.
Source: clinicaltrialsarena.com
Page 19 - Skye Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Skye Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Skye Bioscience Today - Breaking & Trending Today
Skye Bioscience Inc hires CMAX to run its phase 1 study of lead candidate SBI-100 OE for glaucoma
Skye Bioscience inc (OTCQB:SKYE) said it has hired experienced Australian clinical trial operator CMAX to run its phase 1 study of lead candidate SBI-100 OE...
Source: proactiveinvestors.com
US stocks end lower in a choppy session as investors monitor Ukraine-Russia war
4.05pm: Nasdaq drops 1.6% US stocks ended in the red Thursday as investors monitored the latest developments in the Ukraine-Russia conflict as well as the...
Source: proactiveinvestors.com.au
Skye Bioscience Inc. is pioneering a way to unlock the pharmaceutical potential of cannabinoids
Deep Dive - Skye Bioscience Inc
Source: proactiveinvestors.com.au
US stocks end lower in a choppy session as investors monitor Ukraine-Russia war
4.05pm: Nasdaq drops 1.6% US stocks ended in the red Thursday as investors monitored the latest developments in the Ukraine-Russia conflict as well as the...
Source: proactiveinvestors.com